Molecular Geodesics Inc.
This article was originally published in Start Up
Executive SummaryMolecular Geodesics' core patent describes biomimetic materials which posess geodesic features and stabilize through tensegrity. The company hopes to design new biocompatible and bioresorbable materials that can achive desired mechanical behaviors, incorporate bioactive molecular compounds and yet have a high strength to weight ratio.
You may also be interested in...
A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.
The first of around 260 patients for a clinical trial comparing its PB006 natalizumab biosimilar candidate to Biogen’s Tysabri reference brand have been recruited by Polpharma Biologics, which has just added Karsten Roth and Alexandra Moulson to its team.